Kurum Yazarı "Ölmez, Ömer Fatih" Bildiri Koleksiyonu İçin Listeleme
-
Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice
Tural, Deniz; Arslan, Çağatay; Selçukbiricik, Fatih; Ölmez, Ömer Fatih; Erman, Mustafa; Ürün, Yüksel; Karadurmuş, Nuri; Akar, Emre; Kılıçkap, Saadettin (Lippincott Williams & Wilkins, 2022)Background: Anti-tumor activity and manageable safety profile of immune checkpoint blockade therapies (ICT) have been demonstrated in previous clinical trials in patients with metastatic urothelial carcinoma. To the best ... -
The modified glasgow prognostic score (MGPS) and the mortality prediction MODEL II (MPM II) CAN predict mortality in patients with breast cancer admitted to intensive care: A retrospective cohort study
Ölmez, Ömer Fatih; Tunay, Burcu; Bilici, Ahmet; Bayramgil, Ayberk; Çavuşoğlu, Güneş Dorukhan; Öz, Hüseyin (Lippincott Williams and Wilkins, 2022)... -
The relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients.
Bilici, Ahmet; Göktaş Aydın, Sabin; Çakır, Aslı; Ölmez, Ömer Fatih; Erol, Vedat Buğra (Lippincott Williams & Wilkins, 2023)...